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Background
Elite controllers have immune responses capable of mod-
ulating HIV replication. Our goal is to understand the
role for gamma/delta T cells in controlling HIV. These
rare individuals maintain undetectable plasma virus loads
with few or no signs of disease progression despite not
using antiretroviral therapy. High frequencies of “protec-
tive” MHC haplotypes implicated Class I-restricted cyto-
toxic T lymphocytes as one mechanism for virus control
but this cannot explain the majority of individuals who
do not carry these MHC alleles. Neutralizing antibodies
are generally absent among elite controllers, but serum
antibodies are active in antibody-dependent cellular cyto-
toxicity (ADCC) against target cells decorated with HIV
Env glycoprotein. ADCC requires Fc receptor-expressing,
cytotoxic effector cells to mediate destruction of HIV-
infected targets; the nature of ADCC effectors has not
been described for elite HIV controllers.
Methods
Cellular immunology studies with PBMC from elite con-
trollers (designated by us as natural virus suppressors)
and matched uninfected controls.
Results
We noted previously (Riedel, et al., AIDS 23:1955, 2009)
that elite controllers have levels of gamma/delta T cells
higher than matched controls, in sharp contrast to
extensive depletion of this subset expected for indivi-
duals with HIV infection and disease. The Vgamma2V-
delta2+ subset is highly activated in elite controllers;
these cells express CD56, a marker for cytotoxicity, and
CD16, the Fc gamma receptor IIIa that is used for
ADCC. In vitro studies demonstrated potent ADCC
against Env-decorated cell targets using human mono-
clonal antibodies with expanded gamma/delta effector
cells from elite controllers.
Discussion
A distinguishing feature among elite controllers is the
preservation of activated Vgamma2Vdelta2+ T cells cap-
able of mediating ADCC. These studies encourage the
development of immunotherapies to activate gamma/
delta T cells, enhance the effector component of ADCC,
p r o m o t ev i r u sc l e a r a n c ea n ds l o wd i s e a s ep r o g r e s s i o n .
The combination of ADCC antibodies and potent effec-
tor cells corresponds to durable control of viremia and
disease. Early depletion of gamma/delta T cells in HIV
disease may eliminate an important subset needed for
ADCC and, despite strong antibody responses, allow
HIV to persist with progressing disease.
Published: 11 May 2010
doi:10.1186/1742-4690-7-S1-O7
Cite this article as: Poonia et al.: gδT cells are ADCC effectors in elite HIV
controllers. Retrovirology 2010 7(Suppl 1):O7.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
* Correspondence: cdpauza@ihv.umaryland.edu
Institute of Human Virology, University of Maryland Medical School,
Baltimore, MD, USA
Poonia et al. Retrovirology 2010, 7(Suppl 1):O7
http://www.retrovirology.com/content/7/S1/O7
© 2010 Poonia et al; licensee BioMed Central Ltd.